Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
Adamopoulos S, Parissis JT, Georgiadis M, Karatzas D, Paraskevaidis J, Kroupis C, Karavolias G, Koniavitou K, Kremastinos DT. Adamopoulos S, et al. Among authors: kremastinos dt. Am Heart J. 2002 Aug;144(2):359-64. doi: 10.1067/mhj.2002.124052. Am Heart J. 2002. PMID: 12177657 Clinical Trial.
Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy.
Parissis JT, Adamopoulos S, Karatzas D, Paraskevaidis J, Livanis E, Kremastinos D. Parissis JT, et al. Eur J Cardiovasc Prev Rehabil. 2005 Apr;12(2):164-8. doi: 10.1097/01.hjr.0000159320.70090.3d. Eur J Cardiovasc Prev Rehabil. 2005. PMID: 15785303 Clinical Trial.
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT. Adamopoulos S, et al. Among authors: kremastinos dt. Am J Cardiol. 2006 Jul 1;98(1):102-6. doi: 10.1016/j.amjcard.2006.01.068. Epub 2006 May 6. Am J Cardiol. 2006. PMID: 16784930 Clinical Trial.
Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT, Nikolaou M, Birmpa D, Farmakis D, Paraskevaidis I, Bistola V, Katsoulas T, Filippatos G, Kremastinos DT. Parissis JT, et al. Among authors: kremastinos dt. Am J Cardiol. 2009 Jan 1;103(1):73-5. doi: 10.1016/j.amjcard.2008.08.045. Epub 2008 Oct 17. Am J Cardiol. 2009. PMID: 19101233
Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
Adamopoulos S, Parissis J, Karatzas D, Kroupis C, Georgiadis M, Karavolias G, Paraskevaidis J, Koniavitou K, Coats AJ, Kremastinos DT. Adamopoulos S, et al. Among authors: kremastinos dt. J Am Coll Cardiol. 2002 Feb 20;39(4):653-63. doi: 10.1016/s0735-1097(01)01795-8. J Am Coll Cardiol. 2002. PMID: 11849865 Free article. Clinical Trial.
384 results